XML 35 R13.htm IDEA: XBRL DOCUMENT v3.20.1
Cash Equivalents and Short-Term Investments
3 Months Ended
Mar. 31, 2020
Cash and Cash Equivalents [Abstract]  
Cash Equivalents and Short-Term Investments

5. CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

 

Cash equivalents and short-term investments consisted of the following (in thousands):

 

    March 31, 2020  
    Amortized Cost     Unrealized Gains     Unrealized Losses     Market Value  
Cash equivalents:                                
Money market funds   $ 19,065     $     –     $  –     $ 19,065  
Commercial paper     747                   747  
Total cash equivalents (1)     19,812                   19,812  
Short-term investments:                                
Corporate debt securities     994       3             997  
Total short-term investments     994       3             997  
Total   $ 20,806     $ 3     $     $ 20,809  

 

  (1) Included in cash and cash equivalents in the Company’s consolidated balance sheet as of March 31, 2020 in addition to $18.7 million of cash.

 

    December 31, 2019  
    Amortized Cost     Unrealized Gains     Unrealized Losses     Market Value  
Cash equivalents:                                
Money market funds   $ 2,019     $     $     $ 2,019  
Commercial paper     1,020       4             1,024  
U.S. government debt securities     3,761       9             3,770  
Total cash equivalents (1)     6,800       13             6,813  
Short-term investments:                                
Commercial paper     9,986       54             10,040  
Corporate debt securities     8,977       5             8,982  
Total short-term investments     18,963       59             19,022  
Total   $ 25,763     $ 72     $     $ 25,835  

 

  (1) Included in cash and cash equivalents in the Company’s consolidated balance sheet as of December 31, 2019 in addition to $3.4 million of cash.

 

All investments in debt securities held as of March 31, 2020 and December 31, 2019 had maturities of less than one year. For the three months ended March 31, 2020 and 2019, the Company recognized net realized gains on available-for-sale securities of $0.1 million.